Siemens Medical Solutions USA recalled six MAMMOMAT Inspiration operator tables on October 24, 2025. The operator tables were sold with a bus-installation kit, which they are not designed for. This recall affects three units in the U.S. and three internationally.
There were instances where the operator table was sold together with a bus-installation kit. The operator table is not intended and not released for bus installations as it was designed for stationary operation only.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Siemens Medical Solutions USA, Inc or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the MAMMOMAT Inspiration operator table. Model numbers include 10140000, with UDI-DI 04056869009063, and system serial numbers 6734, 6694, 10121, 10309, 10336, and 10342. These units were distributed worldwide, including in Arkansas, California, and New York.
The operator table is not intended for bus installations and is designed solely for stationary operation. Using the table inappropriately could lead to serious operational failures. The FDA classified this recall as Class II, indicating a risk of injury.
There have been no reported injuries or incidents associated with this recall. The potential risks stem from improper use of the operator table in a mobile setting.
Patients and healthcare providers should stop using the MAMMOMAT Inspiration operator table immediately. Contact Siemens Medical Solutions USA, Inc. for further instructions and follow the recall instructions provided.
For more information, contact Siemens Medical Solutions USA, Inc. at their official website or by phone. Additional details are available at the FDA recall notice.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.